DENTSPLY SIRONA Inc. (XRAY) Financials
XRAY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 5.2 billion | 3.9 billion |
| Dec. 31, 2025 | 5.4 billion | 4.1 billion |
| Sept. 30, 2025 | 5.7 billion | 4.2 billion |
| June 30, 2025 | 6.1 billion | 4.1 billion |
XRAY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -12.0 million | 8.0 million |
| Dec. 31, 2025 | 60.0 million | 8.0 million |
| Sept. 30, 2025 | 40.0 million | 6.0 million |
| June 30, 2025 | 16.0 million | 9.0 million |
XRAY Net Income
No data available :(
XRAY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 190.0 million | 2.0 billion | 95.0 million |
| Dec. 31, 2025 | 326.0 million | 2.0 billion | 93.0 million |
| Sept. 30, 2025 | 363.0 million | 2.0 billion | 85.0 million |
| June 30, 2025 | 359.0 million | 2.2 billion | 92.0 million |
XRAY Shares Outstanding
XRAY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 52.0 million | 44.0 million | 353.0 million | - |
| Dec. 31, 2025 | 41.0 million | 40.0 million | 383.0 million | - |
| Sept. 30, 2025 | 39.0 million | 37.0 million | 358.0 million | - |
| June 30, 2025 | 32.0 million | 37.0 million | 343.0 million | - |
XRAY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 880.0 million | 453.0 million |
| Dec. 31, 2025 | 961.0 million | 518.0 million |
| Sept. 30, 2025 | 904.0 million | 463.0 million |
| June 30, 2025 | 936.0 million | 446.0 million |
XRAY Revenue by Segment
XRAY
Price: $9.88
Dividend Yield: 4.36%
Forward Dividend Yield: 6.64%
Payout Ratio: -74.42%
Dividend Per Share: 0.64 USD
Earnings Per Share: -3.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 2.6 million
Ebitda: 187.9 millionMarket Capitalization: 2.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 32
DGR3: 8.76%
DGR5: 10.01%
DGR10: 9.19%
DGR20: 9.04%